Avicanna Executes Multi Year Agreement to Supply Brazilian Pharmaceutical Company with THC and CBD Cannabis Extracts
Ryan Allway July 7th, 2021 Avicanna’s standardized CBD and THC Cannabis Extracts are to be utilized to produce a range of cannabis-derived products for the Brazilian market of 211 million people.  Fulfillment of purchase orders based on preliminary forecasts for 2022 is expected to generate approximately CAD$4 million in... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )